Author

B. Warner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

D. Kobasa· 2 shared R. Vendramelli· 2 shared A. A. Alfaifi· 1 shared A. A. Sultan· 1 shared B. Gasmi· 1 shared B. Sajesh· 1 shared C. Layne· 1 shared D. Beniac· 1 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

D. Kobasa

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

SARS-CoV-2 Infection of Salivary Glands Compromises Oral Antifungal InnateImmunity and Predisposes to Oral Candidiasis

A. A. Alfaifi, T. W. Wang, P. Perez, A. A. Sultan, T. F. Meiller, P. Rock, D. Kleiner, D. S. Chertow, S. Hewitt, B. Gasmi, S. Stein, S. Ramelli, D. Martin, B. Warner, M. A. Jabra-Rizk

This study shows SARS-CoV-2 infection reduces histatin-5 in salivary glands, impairing antifungal immunity and increasing Candida albicans prevalence in COVID-19 patients.

bioRxiv · May 13, 2024 · PreprintMicrobiology

Development and Characterization of Recombinant Vesicular Stomatitis Virus (rVSV)-based Bivalent Vaccine Against COVID-19 Delta Variant and Influenza Virus

Z. Ao, M. Jing Ouyang, T. A. Olukitibi, B. Warner, R. Vendramelli, T. Truong, M. Zhang, S. Kung, K. R. Fowke, D. Kobasa, X. Yao

This study develops and tests a bivalent rVSV vaccine targeting SARS-CoV-2 Delta and influenza, showing strong immune responses and protection in animal models.

bioRxiv · Dec 14, 2021 · PreprintMicrobiology

Single immunization with recombinant ACAM2000 vaccinia viruses expressing the spike and the nucleocapsid proteins protect hamsters against SARS-CoV-2 caused clinical disease

J. Cao, Y. Deschambault, J. Lynch, B. Warner, K. Tierney, D. Huynh, R. Vendramelli, N. Tailor, S. Booth, B. Sajesh, K. Frost, K. LeBlanc, C. Layne, L. Lin, D. Beniac, , D. Kobasa

This study shows that a single immunization with a vaccinia virus expressing both SARS-CoV-2 spike and nucleocapsid proteins protects hamsters better than expressing either protein alone.

bioRxiv · Dec 2, 2021Microbiology